First-trimester maternal serum tumor necrosis factor receptor-1 and pre-eclampsia

Ultrasound in Obstetrics and Gynecology

Volumn 33, Issue 2, 2009, Pages 135-141

  Leal, A M ^a   Poon, L C Y ^a   Frisova, V ^a   Veduta, A ^a   Nicolaides, K H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Doppler; First trimester screening; Pre eclampsia; Tumor necrosis factor; Uterine artery

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR 1;

ADOLESCENT; ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DELIVERY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; PLACENTA PERFUSION; PREECLAMPSIA; PRIORITY JOURNAL; PULSE WAVE; SMALL FOR DATE INFANT; UTERINE ARTERY;

ADOLESCENT; ADULT; ARTERIES; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PULSATILE FLOW; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; UTERUS; YOUNG ADULT;

EID: 59949095870     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.6275     Document Type: Article

References (40)

1. World Health Organization (WHO). Make every mother and child count. World Health Report, 2005.WHO:Geneva, 2005.
2. Lewis G (ed.). Why mothers die 2000-2002: the sixth report of confidential enquiries into maternal deaths in the United Kingdom. RCOG Press: London, 2004.
3. ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin: diagnosis and management of preeclampsia and eclampsia: number 33, January 2002. Obstet Gynecol 2002; 99: 159-167.
4. Brosens I, Robertson WB, Dixon HG. The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol 1967; 93: 569-579.
5. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. BJOG 1986; 93: 1049-1059.
6. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, van Assche A. Placental bed spiral arteries in the hypertensive disorders of pregnancy. BJOG 1991; 98: 648-655.
7. Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341: 1447-1451.
8. Redman CWG. Pre-eclampsia and the placenta. Placenta 1991; 12: 301-308.
9. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 2001; 38: 718-722.
10. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 80: 499-506.
11. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998; 179: 1359-1375.
12. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170: 1752-1759.
13. Serin IS, Ozcelik B, Basbug M, Kilic H, Okur D, Erez R. Predictive value of tumor necrosis alpha (TNF-alpha) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2002; 100: 143-145.
14. Velzing-Aarts FV, Muskiet FA, van der Dijs FP, Duits AJ. High serum interleukin-8 levels in afro-caribbean women with preeclampsia. Relations with tumor necrosis factor-alpha, duffy negative phenotype and von Willebrand factor. Am J Reprod Immunol 2002; 48: 319-322.
15. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with preeclampsia. BJOG 1995; 102: 20-25.
16. Williams MA, Mahomed K, Farrand A, Woelk GB, Mudza-miri S, Madzime S, King IB, McDonald GB. Plasma tumor necrosis factor-alpha soluble receptor p 55 (sTNFp55) concentrations in eclamptic, preeclamptic and normotensive pregnant Zimbabwean women. J Reprod Immunol 1998; 40: 159-173.
17. Sanchez SE, Zhang C, Williams MA, Ware-Jauregui S, Larrabure G, Bazul V, Farrand A. Tumor necrosis factor-alpha soluble receptor p55 (sTNFp55) and risk of preeclampsia in Peruvian women. JReprod Immunol 2000; 47: 49-63.
18. Nunez-Gonzalez JRJ, Johnson Sanabria-Vera C, Romero-Adrian T. Determinacion de las concentraciones sericas de l factor de necrosis tumoral a y de sus receptores solubles en embarazadas normales y preeclampticas. Invest Clin 2001; 42: 171-181.
19. Bowen RS, Moodley J, Dutton MF. Systemic inflammatory indices in preeclampsia and eclampsia. J Obstet Gynecol 2001; 21: 563-569.
20. Visser W, Beckmann I, Knook MA, Wallenburg HC. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia. Acta Obstet Gynecol Scand 2002; 81: 713-719.
21. Madazli R, Aydin S, Uludag S, Vildan O, Tolun N. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet Gynecol Scand 2003; 82: 797-802.
22. Schipper EJI, Bolte AC, Schalkwijk CG, Van Geijn HP, Dekker GA. TNF-receptor levels in preeclampsia result of a longitudinal study in high-risk women. JMatern Fetal Neonatal Med 2005; 18: 283-287.
23. Hamai Y, Fujii T, Yamashita T, Nishina H, Kozuma S, Mikami Y, Taketani Y. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 1997; 38: 89-93.
24. Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zingheim RW, O'Reilly GC, King IB, Zebelman AM, Luthy DA. Maternal second trimester serum tumor necrosis factor-alpha soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol 1999; 149: 323-329.
25. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2007; 30: 742-749.
26. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005; 25: 221-226.
27. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892-898.
28. Gardosi J, Francis A. Software program for the calculation of customized birth weight percentiles. Version 6.2, 2000-2007. http://www.gestation.net [Accessed 15 May 2006].
29. Poon L, Maiz N, Valencia C, Plasencia W, Nicolaides KH. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 2009; 33: 23-33.
30. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001; 86: 2505-2512.
31. Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 2003; 189: 1173-1177.
32. Sebire NJ, Goldin RD, Regan L. Term pre-eclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol 2005; 25: 117-118.
33. Shobokshi A, Shaarawy M. Maternal serum and amniotic fluid cytokines in patients with preterm premature rupture of membranes with and without intrauterine infection. Int J Gynaecol Obstet 2002; 79: 209-215.
34. Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 1992; 166: 1576-1587.
35. Figueroa R, Garry D, Elimian A, Patel K, Sehgal PB, Tejani N. Evaluation of amniotic fluid cytokines in preterm labor and intact membranes. J Matern Fetal Neonatal Med 2005; 18: 241-247.
36. Hillier SL, Witkins SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic choriamnionitis and chorioamnion infection. Obstet Gynecol 1993; 81: 941-948.
37. Annells MF, Hart PH, Mullighan CG, Heatley SL, Robinson JS, Bardy P, McDonald HM. Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-alpha, FAS, and mannose-binding protein C gene polymorphism in Australian women: risk of preterm birth. Am JObstet Gynecol 2004; 191: 2056-2067.
38. Engel SA, Erichsen HC, Savitz DA, Thorp J, Chanock SJ, Olshan AF. Risk of spontaneous preterm birth is associated with common proinflammatory cytokine polymorphisms. Epidemiology 2005; 16: 469-477.
39. Curry AE, Vogel I, Drews C, Schendel D, Skogstrand K, Flanders WD, Hougaard D, Olsen J, Thorsen P. Mid-pregnancy maternal plasma levels of interleukin 2, 6 and 12, tumor necrosis factor-alpha, interferon gamma, and granulocyte-macrophage colony-stimulating factor and spontaneous preterm delivery. Acta Obstet Gynecol Scand 2007; 86: 1103-1110.
40. Bahar AM, Ghalib HW, Moosa RA, Zaki ZM, Thomas C, Nabri OA. Maternal serum interleukin-6, interleukin-8, tumor necrosis factor and interferon in preterm labor. Acta Obstet Gynecol Scand 2003; 82: 543-549.